Wed, Mar 29, 2017 | updated 08:43 AM IST

Post trial scientists develop tablet to prevent kidney cancer relapse

Updated: Oct 12, 2016 12:22 IST

Washington D.C [USA], Oct. 12 (ANI): A recent trial demonstrates that consuming oral tablet Sunitinib for one year reduces the likelihood of cancer returning for kidney cancer patients following removal of the

kidney.

Reportedly, it is the first ever preventative treatment to make a difference to kidney cancer patients after surgery.

Patients with locally advanced kidney cancer usually face a 40 to 50 percent chance of a relapse within five years after having an operation to remove their kidney.

The clinical trial of an adjuvant treatment for patients, who have had kidney cancer, has been carried out by an international team of oncology experts.

The results of the trial are likely to change clinical practice worldwide.

Kidney cancer accounts for 129,000 deaths worldwide each year and patients with locally advanced kidney cancer face a 50 percent risk of it returning within five years once they have had the operation to

remove their kidney.

While adjuvant treatments are routinely used on patients with other types of cancer (such as breast and bowel cancer), no such treatment capable of improving outcomes for kidney cancer patients have been developed yet.

This is despite numerous studies being carried out in this field over the past 20 years.

The recent research demonstrates that by taking the oral tablet Sunitinib for one year, patients are able to reduce the likelihood of their cancer returning.

The trial, a randomised double blind test was conducted with 615 people with stage T3 renal cell carcinoma, some of whom were given Sunitinib and some a placebo.

Patients receiving Sunitinib had improved disease free survival versus those given the placebo (6.8 years versus 5.6 years).

Sunitinib is a tried and tested drug which has been used on patients with metastatic (widespread) renal cancer for around eight years.

In the trial, as expected, the incidence of side-effects in patients taking Sunitinib was higher to those taking the placebo but these side effects were manageable and did not lay impact on the patients' quality of life.

The trial was led in the UK by Hardev Pandha and its lead researcher was Alain Ravaud.

"This trial was undertaken with a very well-defined population of patients who are generally at high risk of relapse. For these patients, it has shown that taking a simple tablet makes a significant difference without causing a significant decrease in quality of life. Since Sunitinib is already widely used in patients with metastatic

cancer, clinicians are familiar with the drug and its side-effects, so are well placed to prescribe it to patients," Pandha said.

The results of the trial were presented during the Presidential Address of the ESMO 2016 Congress in Copenhagen. (ANI)

Ranchi [India], Mar. 28 (ANI): Health Minister of Jharkhand, Ramchandra Chandravanshi has recently claimed that the state has come a long way from the day when Jharkhand was on 18th number among states as far as their healthcare services were concerned. It now stands third in the country, according to an independent survey.

Full Story >>

Washington D.C. [USA], Mar. 28 (ANI): Exposure to fungal product, called aflatoxin, is believed to cause up to 80 percent of liver cancer cases in many parts of the world.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): Attention dog lovers! With just six months of training, a German Shepherd can accurately detect breast cancer, a study finds.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): A recent study has found that a sleepless night impairs your ability to interpret subtle expressions of happiness and sadness.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): When it comes to new moms' workout programs, less is more and so, according to a Kansas State University researcher, new moms may need a bit more flexibility and support to ease back into exercise after giving birth.

Full Story >>

New approach to diagnosing mental disorders

Updated: Mar 26, 2017 10:48 IST

Washington D.C. [USA], Mar. 26 (ANI): A consortium of psychiatrists and psychologists has proposed a new approach to diagnosing mental disorders.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): Boosting natural brain opioids may be a better way to treat anxiety, according to a recent study.

Full Story >>

Fecal transplant offers hope for autistic kids

Updated: Mar 26, 2017 09:37 IST

Washington D.C. [USA], Mar. 26 (ANI): In this new era of medical therapy dawning, fecal transplants are poised to help fight a range of conditions, from deadly superbugs to obesity and now, autism is in the firing line.

Full Story >>

Thiruvallur (Chennai) [India], Mar. 25 (ANI): A highly contagious viral disease of cattle and swine, Foot-and-Mouth Disease (FMD) has affected Karani village on the outskirts of Tamil Nadu's Tiruvallur district.

Full Story >>

New Delhi [India], Mar. 25 (ANI): The findings of the National Family Health Survey 2015-16 confirm what we all knew from clinical evidence - that hypertension has become a major health concern among the Indian population, with as many as 22% Indians hypertensive.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A prescription weight-loss medication can decrease the urge to use opiates such as oxycodone, according to a recent study.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has discovered a new gene that is associated with Tau accumulation, which is one of the defining features of Alzheimer disease (AD).

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): All it takes is the flip of a protein "switch" within the tiny wire-like capillaries of the brain to increase the blood flow that ensures optimal brain function.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): Scientists have found that stem cell therapy repairs damaged lungs - raising hopes of a cure for the crippling chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

Full Story >>

New method can cut dental implant failure

Updated: Mar 25, 2017 09:34 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a new method to reduce dental implant failure.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a fluorogenic probe that can detect the activity of multidrug-resistant pathogens in an assay system.

Full Story >>

Virus hydrophobicity can help purify vaccines

Updated: Mar 25, 2017 07:46 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has found that hydrophobic proteins on virus surfaces can help purify vaccines.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has shed light on why survivors of childhood brain tumours may be prone to heart disease, stroke, type 2 diabetes and early death.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Continuing its efforts to raise awareness on tuberculosis and its diagnosis, Division of Clinical Microbiology & Molecular Medicine Department of Laboratory Medicine, AIIMS, and BD (Becton Dickinson India) for the third consecutive year organized a symposium today on "challenges in diagnosis and eradication of tuberculosis".

Full Story >>

New Delhi [India], Mar. 24 (ANI): On the solemn occasion of World Tuberculosis (TB) Day, Members of Parliament, policymakers, TB patients, survivors, and citizens of the civil society gathered at India Gate on Thursday, March 23 to pay tribute to the nearly five lakh lives lost due to this disease last year.

Full Story >>